A new lump after Sculptra needs assessment because swelling, nodules, inflammation and infection require different responses. This guide explains the types of lumps described in FDA documents, how a provider may assess them, which treatments may be considered, and which symptoms need prompt or emergency care.
Can a Sculptra lump simply be dissolved?
Not the way hyaluronic acid (HA) filler sometimes can be. According to the FDA, Sculptra is made of poly-L-lactic acid (PLLA), carboxymethylcellulose and mannitol. Hyaluronidase is used off-label to reduce HA filler; it does not dissolve Sculptra. The FDA also cautions that removal may be difficult or impossible for fillers not made of HA, and that removal procedures carry their own risks. So the useful question is "what is this lump, and what does my provider recommend?"
What kinds of lumps can happen after Sculptra?
Swelling, tenderness and small bumps at injection points can appear in the days after any filler treatment. The FDA notes that most filler side effects such as swelling and bruising appear shortly after injection, while some, such as raised bumps under the skin (nodules or granulomas), may appear weeks, months or years later.
The FDA's Summary of Safety and Effectiveness Data for Sculptra describes several kinds of lumps reported after marketing:
- Papules and nodules. Small bumps or firm lumps, sometimes with inflammation or skin discoloration. Injection-site nodules mostly occurred several months after injection, with reported onset from about one to two months up to 14 months after the last injection.
- Granulomas. An inflammatory reaction to foreign material. These usually appeared several months after injection and, in a few cases, more than a year later. Only a few reported cases were confirmed by biopsy.
- Mass or firmness (induration). Areas that feel hard or thickened.
The Sculptra labeling defines a papule as a small lump under 5 mm and a nodule as one 5 mm or larger. Papules and nodules may be palpable without being visible or painful, but symptoms vary; report new lumps to your treating clinician. The labeling asks patients to report these and any other adverse reactions to their provider.
Sculptra works gradually. The American Society for Dermatologic Surgery (ASDS) describes PLLA as a biostimulatory filler that prompts your skin to produce collagen, with effects that appear over a few months. That slow timeline is one reason a lump that appears well after treatment should still be reported, even if your treatment felt routine.
Why do Sculptra nodules form?
Sculptra material behaves differently from a gel filler. According to its FDA labeling, Sculptra is an injectable implant containing microparticles of PLLA that a clinician mixes with sterile water into a suspension before treatment. The treatment effect develops gradually over several weeks, which is why the labeling tells injectors not to overfill at any session.
The labeling links several factors to Sculptra nodules and papules:
- Injection depth. Superficial injections may be associated with more nodules and papules, and the labeling calls for special care in people with thin skin.
- Treatment area. Sculptra injections around the eyes have not been studied, and published reports describe a higher risk of papules and nodules there. Sculptra should not be injected into the red part of the lips.
- Volume. Interim results from an ongoing post-approval study suggest the risk may be associated with larger injection volumes and more severe wrinkles before treatment, particularly in the marionette lines.
- Training and anatomy. To reduce the risk of complications such as papules and nodules, the labeling says Sculptra should be used only by professionals with appropriate training and experience who know the anatomy of the injection site.
Proper injection technique is part of lowering the risk, and the warning about superficial injections shows how improper injection technique may raise it. In the post-approval study reported in the labeling, 28.4% of 867 treated participants had nodules or papules through three years of follow-up across the treated facial areas; rates varied substantially between study sites. A lump on its own does not show what caused it, which is why it needs an examination.
How does a provider assess a lump?
Expect questions and an examination rather than an immediate fix. Your provider may ask:
- When the lump appeared, and whether it is growing, shrinking or staying the same
- Whether it is tender, red, warm or discolored, or has drained any fluid
- How many Sculptra sessions you had, when, and in which areas
- Whether you have had other fillers or procedures in the same area, and which products were used
- Whether you have had a recent illness, dental work or other procedure
If you were treated elsewhere, bring the product name and treatment dates if you have them. The FDA advises knowing the type of product injected and where each product was placed. Some lumps may need a biopsy or a referral to a specialist before the cause is clear. The labeling also notes that Sculptra microparticles may be visible on ultrasound or MRI, so tell anyone imaging your face that you have had Sculptra.
What treatments might a provider consider?
The FDA summary lists treatments that have been used for reported Sculptra side effects, depending on the event: massage or manipulation, warm compresses, corticosteroids, antibiotics, antihistamines, anti-inflammatory medicines, aspiration or drainage of the product, saline injections and surgery.
For nodules, the summary reports that some resolved on their own or after corticosteroid injections into the lump, while others lasted up to two years. Larger nodules, nodules in difficult areas such as the lower eyelid, and nodules that persisted after other treatment sometimes required surgical removal. Reported granuloma treatment ranged from subcision or corticosteroid injection to surgical extraction.
Each of these options has its own risks and may not suit your situation. Ask why a particular approach is being recommended, what the alternatives are, and what to expect if the lump is simply monitored for a time.
What should you avoid doing at home?
- Do not squeeze, puncture or try to drain a lump.
- Do not buy or inject any product to "dissolve" filler. The FDA warns against injecting yourself with dermal fillers or buying filler products sold directly to the public.
- Follow only the aftercare your provider gave you. The American Academy of Dermatology notes that PLLA may require gentle massage of the treated area for a period after treatment and that your dermatologist will tell you whether you need to massage. The Sculptra labeling recommends circular massage of treated areas for 5 minutes, 5 times a day for 5 days after each session, according to your provider's advice. Ask before applying massage, heat or any new product to a lump that appears later.
When should you contact your provider or seek emergency care?
Contact your treating provider about any new lump, a lump that is growing, firmness that does not settle, or skin color changes over a treated area, even if they appear months after your last session.
Contact your provider the same day about redness, warmth, increasing pain, swelling, drainage or fever near a treated area. The FDA summary reports serious infections, including abscesses and cellulitis, that began from one day to one week after injection.
Seek emergency care for vision changes, skin near the injection site that turns white, gray or blue, unusual pain, or any sign of a stroke, such as sudden difficulty speaking, face drooping, or weakness or numbness in the face, arms or legs. The FDA advises immediate medical attention for these symptoms. Swelling of the face, lips or throat with trouble breathing or swallowing also needs emergency care.
Questions to ask about a lump after Sculptra
- What do you think this lump is, and how sure are you?
- Does it need treatment now, or can it be monitored? For how long?
- What are the risks of each treatment option, including injections or surgery?
- Should I change anything about my aftercare or future sessions?
- Which symptoms should make me call you sooner?
Prepare for a visit with the aesthetic treatment consultation checklist, learn about facial aesthetics at Anew Laser MD, or use the contact page to ask about an assessment and whether Sculptra is offered at your location. Your treating provider's instructions come first.
Independent sources
- FDA: Sculptra instructions for use and labeling (P030050/S039)
- FDA: Sculptra Summary of Safety and Effectiveness Data
- FDA: dermal fillers (soft tissue fillers)
- FDA: Hylenex recombinant (hyaluronidase human injection) prescribing information, revised 01/2024 (approved uses do not include filler removal)
- American Society for Dermatologic Surgery: injectable poly-L-lactic acid
- American Academy of Dermatology: fillers FAQs
Learn about Facial Aesthetics at Anew Laser MD
General educational information is not a diagnosis or treatment recommendation. Consult a qualified clinician about your individual circumstances.
